EVE

EVEHEALTH FPO [EVE]
EVE Health Group Limited, together with its subsidiaries, engages in the development, retail, and commercialization of health and wellness, and pharmaceutical products. The company lead product is Dyspro, a proprietary pharmaceutical-grade formulation to address dysmenorrhea (menstrual pain); and Libbo, a proprietary pharmaceutical-grade oral dissolving film formulation for the treatment of erectile dysfunction. It also offers Lactobacillus rhamnosus Beebiotic MAP01, a proprietary strain to support digestive health and vitality. The company was formerly known as EVE Investments Limited. EVE Health Group Limited was incorporated in 2003 and is based in Subiaco, Australia.
Consumer Defensive · ASX Small Cap
$0.0150 +0.0%

Updated 3 Sep 2026 · Signals refresh every scan

⚠ Funding Risk — Cash runway under 4 quarters. Capital raise or funding may be required.
Appeared in 2 consecutive scansFirst seen: 2026-02-25
Get alerts when EVE triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track EVE — Free

Active Signals

Bullish Signals

  • RSI drifting toward oversold territory — worth watching
  • Low cash runway (2 quarters) - dilution risk
  • 4C filed 2026-08-07
  • Low P/S ratio (3.9x)
  • Revenue in sharp decline (-37%)
  • Near 52-week low (5% of range)
  • Micro-cap ($5-20M) - high risk
  • CANSLIM S: Tight float (36%)
  • Sentiment is mixed — no strong consensus either way
  • Penny stock risk ($0.015)
  • RBA hiking (-3pts)

Risk Signals

  • Below the 200-day average — the long-term trend is still working against it
  • Piotroski F-Score weak (3/9, low-confidence approx)
  • Deeply negative margins (-119%)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Long-term momentum is negative — down 36% over the past year
  • Revenue declining at -37% — the top line is shrinking
  • The bigger volume days are the down days — volume-weighted momentum is negative (-2.06%/day)
Ask Scout AI about EVE
"What's driving EVE today?" "How does EVE compare to peers?" "Key risks for EVE?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Release of Securities from Escrow
NONE Appendix 4G and Corporate Governance Statement
NONE Appendix 4E
LOW Annual Report to shareholders
LOW Quarterly Activities/Appendix 4C Cash Flow Report - Amended

Recent ASX Announcements

2026-09-03 Release of Securities from Escrow
2026-08-31 Appendix 4G and Corporate Governance Statement
2026-08-31 Annual Report to shareholders
2026-08-31 Appendix 4E PRICE SENSITIVE
2026-08-07 Quarterly Activities/Appendix 4C Cash Flow Report - Amended PRICE SENSITIVE

Key Metrics

$5.3M
Market Cap
423K
Avg Volume
1.0x
Vol Ratio
$0.01 — $0.04
52-Week Range
N/A
Short Interest
2 qtrs
Cash Runway
-77.7%
ROE
-119.1%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandpassFloat: 36%
LLeader vs LaggardlaggardRS: -16
IInstitutional Sponsorshipinsufficient_dataInst: 0%
MMarket DirectionneutralNeutral

Sector: Consumer Defensive

39 tickers in this sector

View all Consumer Defensive signals →Browse all ASX tickers A–Z →
Related Tickers
BIO +9.2%DBF -6.5%BUB +5.7%MBH -5.4%FRM +3.9%
Compare:EVE vs BIOEVE vs DBFEVE vs BUB
Scout Pro — Deeper Analysis for EVE
Try Pro free for 30 days
Share this analysis

Track EVE and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required